Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309880 · ClinicalTrials.gov registry record · NA
Evaluation of a New Silicone Hydrogel Contact Lens
A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT01309880: Completed NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
NCT01309880 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 66 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01309880, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.
Primary Outcome
Distance high contrast logMAR lens visual acuity (VA) between the Air Optix Aqua lens and the Test Lens at Dispensing and at 1-Week Follow-up.
Conditions Studied
Interventions
- DEVICE Test lens
- DEVICE Air Optix Aqua
Study Locations (1)
New York
- Bausch & Lomb, Incorporated - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT01309880 record still lists
NCT01309880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Test lens is the first listed.
NCT01309880 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01309880 about?
NCT01309880 is a clinical study titled "Evaluation of a New Silicone Hydrogel Contact Lens". The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.
What is the current status of trial NCT01309880?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-12. Estimated completion is 2011-01.
What conditions does trial NCT01309880 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01309880?
The interventions under investigation include: Test lens (DEVICE), Air Optix Aqua (DEVICE).
Who is sponsoring clinical trial NCT01309880?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01309880 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01309880's enrollment target sits among peer trials
66 53rd of 90 higher than 35 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia